(Q33699376)

28 July 2017

title

Does the timing of esophagectomy after chemoradiation affect outcome? (English)

1 reference

28 July 2017

0 references

8

Jaffer A Ajani

1 reference

28 July 2017

14

Wayne L Hofstetter

1 reference

28 July 2017

13

Stephen G Swisher

1 reference

28 July 2017

3

Ara A Vaporciyan

1 reference

28 July 2017

7

David C Rice

1 reference

28 July 2017

2

Arlene M Correa

1 reference

28 July 2017

10

Manoop S Bhutani

1 reference

28 July 2017

9

Dipen M Maru

1 reference

28 July 2017

5

Reza J Mehran

1 reference

28 July 2017

4

Jack A Roth

1 reference

28 July 2017

6

Garrett L Walsh

1 reference

28 July 2017

12

Edith M Marom

1 reference

28 July 2017

Jae Y Kim

1

1 reference

28 July 2017

James Welsh

series ordinal

11

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 October 2011

1 reference

The Annals of Thoracic Surgery

28 July 2017

published in

1 reference

28 July 2017

volume

93

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

207-12; discussion 212-3

1 reference

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Current management for late normal tissue injury: radiation-induced fibrosis and necrosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Optimal timing of surgery after preoperative chemoradiotherapy for rectal cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4041623

Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer

30 October 2018

1 reference

12 December 2020

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

12 December 2020

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

12 December 2020

Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis

1 reference

12 December 2020

10.1016/J.ATHORACSUR.2011.05.021

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference